Buy Fractional Shares of Top US Stocks. Start Investing with just $1!
+91
US Drug Manufacturers Stocks
as onThis industry covers large, established pharmaceutical companies with broad drug portfolios, including Pfizer, Merck, and Eli Lilly. Revenue is driven by patented blockbuster drugs, patent expiry cycles, and pipeline development, with regulatory approvals and drug pricing policy playing a major role in stock performance. Upcoming patent cliffs and pipeline refills are closely tracked themes.
Name | LTP | Change % | Volume | Market Cap (Mn)  | PE Ratio | Industry PE | 52W High | 1M Returns | 3M Returns | 1 Yr Returns | 3 Yr Returns | 5 Yr Returns | ROE | ROCE |
|---|
$1,362.41 | -0.17% | 25,55,494 | $1,281,682 | 39.43 | 58.02 | $1,292.65 | 19.13% | 16.50% | 47.16% | 128.90% | 414.12% | 104.62% | 39.76% | |
$276.32 | 1.47% | 49,45,562 | $665,190 | 31.06 | 58.02 | $281.07 | 9.32% | 7.25% | 48.56% | 82.15% | 69.08% | 34.46% | 23.45% | |
$291.46 | 1.12% | 32,90,940 | $515,193 | 72.17 | 58.02 | $285.40 | 9.69% | 18.39% | 34.46% | 106.42% | 148.73% | - | 9.63% | |
$146.82 | -0.08% | 48,84,204 | $361,945 | 117.74 | 57.72 | $156.92 | 5.27% | 14.41% | 73.98% | 40.71% | 79.90% | 36.81% | 23.02% | |
$162.65 | 0.44% | 18,08,060 | $330,959 | 23.23 | 58.02 | $170.46 | 15.45% | 5.32% | 29.60% | 74.05% | 94.44% | 32.50% | 22.92% | |
$186.51 | -0.18% | 23,54,703 | $289,291 | 24.32 | 58.02 | $212.71 | 19.16% | 15.53% | 14.92% | 45.60% | 47.81% | 23.14% | 17.24% | |
$460.35 | 0.02% | 13,50,678 | $249,008 | 26.86 | 58.02 | $447.03 | 14.27% | 12.90% | 43.92% | 68.73% | 115.35% | 102.03% | 17.46% | |
$166.91 | -0.39% | 29,28,674 | $207,024 | 18.38 | 57.72 | $157.29 | 15.45% | 26.63% | 36.16% | 105.70% | 151.67% | 41.55% | 22.86% | |
$29.40 | 1.37% | 3,48,60,395 | $167,564 | 36.79 | 58.02 | $29.49 | 7.31% | 14.03% | 19.46% | -5.72% | -39.52% | 8.72% | 5.62% | |
$40.33 | 0.07% | 81,63,525 | $136,714 | 11.15 | 58.02 | $64.16 | 7.44% | -9.33% | -16.78% | -60.10% | -28.89% | 62.92% | 48.33% | |
$62.18 | -1.50% | 58,75,487 | $127,109 | 14.67 | 57.72 | $68.64 | 5.81% | -2.27% | 33.82% | 17.80% | 4.60% | 40.00% | 16.51% | |
$47.04 | 0.27% | 34,34,516 | $113,625 | 23.63 | 57.72 | $52.68 | 19.06% | 9.93% | -4.00% | 3.98% | -8.29% | 7.11% | 6.53% | |
$50.35 | -0.13% | 27,66,937 | $101,836 | 16.01 | 57.72 | $61.70 | 8.21% | -2.19% | 7.83% | 44.71% | -7.39% | 41.47% | 20.46% | |
$21.01 | -0.84% | 26,61,438 | $67,332 | 69.58 | 57.72 | $19.10 | 17.95% | 25.69% | 54.61% | 53.26% | 47.45% | 1.49% | 2.31% | |
$42.59 | 1.94% | 52,03,988 | $49,697 | 60.73 | 57.72 | $42.02 | 7.49% | 22.71% | 73.14% | 370.63% | 366.51% | 21.09% | 7.77% | |
$9.14 | -0.16% | 1,73,84,014 | $40,158 | 20.81 | 58.02 | $11.28 | 3.51% | -8.27% | -1.88% | 12.64% | 23.28% | 10.38% | 8.80% | |
$248.45 | 1.85% | 6,46,968 | $36,726 | 38.81 | 57.72 | $238.24 | 11.14% | 20.18% | 61.93% | -0.07% | -10.85% | 7.36% | 6.94% | |
$79.40 | -3.30% | 45,91,661 | $32,812 | 12.72 | 58.02 | $148.30 | 11.21% | 6.71% | -34.10% | -51.34% | -63.36% | 57.78% | 29.45% | |
$561.95 | -0.67% | 3,43,117 | $23,933 | 18.46 | 57.72 | $609.35 | 4.83% | 8.36% | 25.59% | 146.28% | 177.78% | 19.56% | 21.92% | |
$19.92 | 5.02% | 1,12,07,253 | $22,882 | - | 58.02 | $18.43 | 13.13% | 12.90% | 85.32% | 116.31% | 45.10% | -22.03% | -9.95% | |
$11.42 | 0.88% | 13,64,154 | $18,247 | 14.67 | 58.02 | $17.26 | -9.50% | -6.44% | -9.29% | 18.71% | 26.33% | 9.00% | 6.85% | |
$164.56 | 3.00% | 11,54,657 | $16,657 | 22.59 | 58.02 | $186.12 | 14.05% | 1.80% | 7.03% | 44.34% | 76.55% | 17.00% | 17.84% | |
$31.16 | -2.66% | 17,20,890 | $13,046 | 19.71 | 57.72 | $37.51 | 15.80% | 3.45% | -15.24% | 28.75% | -16.13% | 7.88% | 7.61% | |
$25.72 | 8.60% | 99,26,735 | $12,848 | - | 58.02 | $27.98 | 14.19% | -1.78% | 19.06% | 174.74% | -24.56% | -3.57% | -0.03% | |
$45.89 | 3.04% | 12,02,245 | $7,712 | 124.76 | 58.02 | $55.67 | 7.48% | -7.51% | 47.71% | 83.64% | 51.31% | 14.82% | 14.73% |
Total 101 records
*The scrips mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
Invest in US Stocks with Dhan
Start building a global portfolio from just $1.
4.5 ratings
4.0 ratings
